Are ECG monitoring recommendations before prescription of QT‐prolonging drugs applied in daily practice? The example of haloperidol

Publisher: John Wiley & Sons Inc

E-ISSN: 1099-1557|24|7|701-708

ISSN: 1053-8569

Source: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol.24, Iss.7, 2015-07, pp. : 701-708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract